SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000950170-23-065147
Filing Date
2023-11-20
Accepted
2023-11-20 16:45:39
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3/A sabs_s-3a_2023pipe_resal.htm S-3/A 395748
2 EX-5.1 sabs-ex5_1.htm EX-5.1 28781
3 EX-23.1 sabs-ex23_1.htm EX-23.1 3011
4 GRAPHIC img84541401_0.jpg GRAPHIC 8342
5 GRAPHIC img84541401_1.jpg GRAPHIC 8342
6 GRAPHIC img208597776_0.jpg GRAPHIC 12897
7 GRAPHIC img208597776_1.jpg GRAPHIC 5023
  Complete submission text file 0000950170-23-065147.txt   476868
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-275319 | Film No.: 231423339
SIC: 2836 Biological Products, (No Diagnostic Substances)